CO5540381A2 - Derivados de imidazotriacinonas y su uso contra procesos inflamatorios y/o enfermedades inmunitarias - Google Patents

Derivados de imidazotriacinonas y su uso contra procesos inflamatorios y/o enfermedades inmunitarias

Info

Publication number
CO5540381A2
CO5540381A2 CO03108302A CO03108302A CO5540381A2 CO 5540381 A2 CO5540381 A2 CO 5540381A2 CO 03108302 A CO03108302 A CO 03108302A CO 03108302 A CO03108302 A CO 03108302A CO 5540381 A2 CO5540381 A2 CO 5540381A2
Authority
CO
Colombia
Prior art keywords
optionally substituted
imidazotriacinonas
derivatives
inflammatory processes
immune diseases
Prior art date
Application number
CO03108302A
Other languages
English (en)
Spanish (es)
Inventor
Cristina Alonso-Alija
Gielen Heike
Martin Hendrix
Niewohner Ulrich
Schauss Dagmar
Bischoff Hilmar
Burkhardt Nils
Geiss Volker
Karl-Heinz Schlemmer
J Cuthbert Nigel
Mary Fitzgerald
Sturton Graham
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of CO5540381A2 publication Critical patent/CO5540381A2/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CO03108302A 2001-06-01 2003-12-10 Derivados de imidazotriacinonas y su uso contra procesos inflamatorios y/o enfermedades inmunitarias CO5540381A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0113344.6A GB0113344D0 (en) 2001-06-01 2001-06-01 Novel heterocycles 3

Publications (1)

Publication Number Publication Date
CO5540381A2 true CO5540381A2 (es) 2005-07-29

Family

ID=9915717

Family Applications (1)

Application Number Title Priority Date Filing Date
CO03108302A CO5540381A2 (es) 2001-06-01 2003-12-10 Derivados de imidazotriacinonas y su uso contra procesos inflamatorios y/o enfermedades inmunitarias

Country Status (28)

Country Link
US (2) US7115602B2 (cs)
EP (1) EP1399447A1 (cs)
JP (1) JP2004536078A (cs)
KR (1) KR20040023605A (cs)
CN (1) CN1512993A (cs)
BG (1) BG108381A (cs)
BR (1) BR0210910A (cs)
CA (1) CA2449095A1 (cs)
CO (1) CO5540381A2 (cs)
CZ (1) CZ295609B6 (cs)
EC (1) ECSP034872A (cs)
EE (1) EE200300570A (cs)
GB (1) GB0113344D0 (cs)
GT (1) GT200200099A (cs)
HR (1) HRP20031090A2 (cs)
HU (1) HUP0400773A3 (cs)
MX (1) MXPA03010985A (cs)
NO (1) NO20035324D0 (cs)
NZ (1) NZ529848A (cs)
PE (1) PE20030231A1 (cs)
PL (1) PL366906A1 (cs)
RU (1) RU2003138078A (cs)
SK (1) SK14672003A3 (cs)
SV (1) SV2003001061A (cs)
UA (1) UA75149C2 (cs)
UY (1) UY27312A1 (cs)
WO (1) WO2002098879A1 (cs)
ZA (1) ZA200309111B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2388111A (en) * 2002-05-01 2003-11-05 Bayer Ag Novel imidazotriazinone compounds
GB2388594A (en) * 2002-05-16 2003-11-19 Bayer Ag Imidazo-triazine PDE 4 inhibitors
FR2850653A1 (fr) * 2003-02-04 2004-08-06 Univ Pasteur Derives de pyrazolotriazine, procede de preparation et utilisations
JP2006219374A (ja) 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Pde7阻害作用を有するイミダゾトリアジノン誘導体
TW200745106A (en) * 2005-10-03 2007-12-16 Astrazeneca Ab Chemical compounds
WO2012123406A1 (en) 2011-03-17 2012-09-20 Algiax Pharmaceuticals Gmbh Novel use of imidazotriazinones
WO2013156231A1 (en) * 2012-04-16 2013-10-24 Algiax Pharmaceuticals Gmbh Use of imidazotriazinones in neuropathic pain
CA2942446A1 (en) * 2014-03-28 2015-10-01 Algiax Pharmaceuticals Gmbh Treatment of cognitive disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791025A (fr) * 1971-11-19 1973-05-07 Allen & Hanburys Ltd Composes heterocycliques
GB1457873A (en) 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DK109578A (da) 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
NZ504436A (en) * 1997-11-12 2001-08-31 Bayer Ag 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
DE19827640A1 (de) * 1998-06-20 1999-12-23 Bayer Ag 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone
US6503908B1 (en) * 1999-10-11 2003-01-07 Pfizer Inc Pharmaceutically active compounds

Also Published As

Publication number Publication date
UY27312A1 (es) 2003-02-28
CZ295609B6 (cs) 2005-08-17
HUP0400773A2 (hu) 2004-07-28
SV2003001061A (es) 2003-03-18
NZ529848A (en) 2006-02-24
HRP20031090A2 (en) 2005-08-31
MXPA03010985A (es) 2004-10-28
CA2449095A1 (en) 2002-12-12
SK14672003A3 (sk) 2004-08-03
KR20040023605A (ko) 2004-03-18
EP1399447A1 (en) 2004-03-24
WO2002098879A1 (en) 2002-12-12
RU2003138078A (ru) 2005-05-27
US20030139415A1 (en) 2003-07-24
ZA200309111B (en) 2004-11-24
BR0210910A (pt) 2004-06-08
GB0113344D0 (en) 2001-07-25
BG108381A (bg) 2004-11-30
ECSP034872A (es) 2004-01-28
US7115602B2 (en) 2006-10-03
US20050065153A1 (en) 2005-03-24
CZ20033275A3 (en) 2004-03-17
HUP0400773A3 (en) 2007-09-28
GT200200099A (es) 2003-02-13
PE20030231A1 (es) 2003-05-16
CN1512993A (zh) 2004-07-14
PL366906A1 (en) 2005-02-07
UA75149C2 (en) 2006-03-15
EE200300570A (et) 2004-04-15
NO20035324L (no) 2003-11-28
NO20035324D0 (no) 2003-11-28
JP2004536078A (ja) 2004-12-02

Similar Documents

Publication Publication Date Title
AR053567A1 (es) Derivados de pirazoliloxifenilo sustituidos, composiciones herbicidas que los contienen y un procedimiento para combatir plantas no deseadas que los comprende.
CY1107236T1 (el) Παραγωγα της 2-αμινο-3-(αλκυλο)-πυριμιδονης ως gsk3. βητα αναστολεις
CY1110064T1 (el) Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης
CY1108792T1 (el) Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
CY1105915T1 (el) Παραγωγα θειαζολιου για τη θepαπεια των παθησεων που σχετιζονται με τους ppar
AR106237A2 (es) Inhibidores heterocíclicos de la aspartil proteasa, sus sales farmacéuticamente aceptables
DOP2011000301A (es) Derivados de azaadamantano y metodos de uso de los mismos
DK1483265T3 (da) Purinderivater som kinaseinhibitorer
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
CR9690A (es) 3-acilaminobenzanilidas insecticidas
ES2183548T3 (es) Dihidropirimidinas.
UY29176A1 (es) Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen, métodos para su preparación y sus usos.
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
AR044706A2 (es) Procedimientos para preparar 4-aminoquinolinas, inhibidores de cetp
CY1106132T1 (el) Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
UY29446A1 (es) Derivados de ciclopentapiridina y tetrahidroquinolina
DOP2006000045A (es) Derivados del (1,5-difenil-1h-pirazol-3-il oxadiazol, su preparacion y su aplicacion en terapeutica
CY1105784T1 (el) Εκδοχα της πιπepαζινυλακυλπιπepιδινης η παρασκευη τους και η εφαρμογη τους στη θepαπευτικη
AR054559A1 (es) Derivados de purina como inhibidores del receptor a2a de adenosina
CO5540381A2 (es) Derivados de imidazotriacinonas y su uso contra procesos inflamatorios y/o enfermedades inmunitarias
NO20061317L (no) Imidazopyridinderivater som induserbare NO-syntaseinhibatorer
AR045326A1 (es) Derivados de aminoquinolina y su uso como ligandos a3 de adenosina
CO6311082A2 (es) Derivados de sulfonil-quinolina, procesos para su preparación y composiciones farmacéuticas que los contienen
AR046768A1 (es) Derivados de piridin-tetrazol, metodos de obtencion y composiciones farmaceuticas

Legal Events

Date Code Title Description
FC Application refused